ID24933A - Kombinasi komponen aktif untuk perawatan senile dementia dari jenis alzheimer - Google Patents

Kombinasi komponen aktif untuk perawatan senile dementia dari jenis alzheimer

Info

Publication number
ID24933A
ID24933A IDW20000860A ID20000860A ID24933A ID 24933 A ID24933 A ID 24933A ID W20000860 A IDW20000860 A ID W20000860A ID 20000860 A ID20000860 A ID 20000860A ID 24933 A ID24933 A ID 24933A
Authority
ID
Indonesia
Prior art keywords
alzheimer
types
combination
active components
senile dementia
Prior art date
Application number
IDW20000860A
Other languages
English (en)
Indonesian (id)
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of ID24933A publication Critical patent/ID24933A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW20000860A 1997-11-14 1998-11-09 Kombinasi komponen aktif untuk perawatan senile dementia dari jenis alzheimer ID24933A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer

Publications (1)

Publication Number Publication Date
ID24933A true ID24933A (id) 2000-08-31

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000860A ID24933A (id) 1997-11-14 1998-11-09 Kombinasi komponen aktif untuk perawatan senile dementia dari jenis alzheimer

Country Status (27)

Country Link
EP (1) EP1030671A1 (is)
JP (1) JP2001523642A (is)
KR (1) KR100599350B1 (is)
CN (1) CN1243540C (is)
AU (1) AU743228B2 (is)
BG (1) BG64819B1 (is)
BR (1) BR9814035A (is)
CA (1) CA2309966A1 (is)
CO (1) CO4980891A1 (is)
DZ (1) DZ2649A1 (is)
EA (1) EA003255B1 (is)
EE (1) EE04235B1 (is)
HU (1) HUP0100098A3 (is)
ID (1) ID24933A (is)
IL (2) IL136122A0 (is)
IS (1) IS5482A (is)
MY (1) MY120461A (is)
NO (1) NO20002450L (is)
NZ (1) NZ504420A (is)
OA (1) OA11464A (is)
PL (1) PL194597B1 (is)
SA (1) SA98190747B1 (is)
SK (1) SK286040B6 (is)
TR (1) TR200001262T2 (is)
TW (1) TW585766B (is)
UY (1) UY25247A1 (is)
WO (1) WO1999025363A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105830A1 (ja) * 2002-06-14 2003-12-24 富山化学工業株式会社 脳機能を改善する医薬組成物および脳機能を改善するための方法
US20060160079A1 (en) * 2002-08-07 2006-07-20 Lane Roger M Methods for the treatment of dementia based on apo e genotype
CN1520818A (zh) * 2003-02-09 2004-08-18 ɽ����Ҷ��Ȼҩ���о��������޹�˾ 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (da) 2017-05-15 2026-03-02 Cognition Therapeutics Inc Sammensætninger til behandling af neurogenerative sygdomme
KR102224917B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CA2213000A1 (en) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
BG64819B1 (bg) 2006-05-31
PL194597B1 (pl) 2007-06-29
EP1030671A1 (fr) 2000-08-30
IL136122A (en) 2006-07-05
SA98190747B1 (ar) 2006-11-04
MY120461A (en) 2005-10-31
DZ2649A1 (fr) 2004-12-28
CA2309966A1 (en) 1999-05-27
IS5482A (is) 2000-05-09
JP2001523642A (ja) 2001-11-27
PL340500A1 (en) 2001-02-12
AU743228B2 (en) 2002-01-24
OA11464A (en) 2003-11-18
EA200000412A1 (ru) 2000-12-25
SK7112000A3 (en) 2000-10-09
KR100599350B1 (ko) 2006-07-12
EE200000290A (et) 2001-06-15
IL136122A0 (en) 2001-05-20
BR9814035A (pt) 2000-09-26
TW585766B (en) 2004-05-01
WO1999025363A1 (fr) 1999-05-27
CO4980891A1 (es) 2000-11-27
UY25247A1 (es) 2001-05-31
CN1243540C (zh) 2006-03-01
BG104428A (en) 2001-08-31
NO20002450D0 (no) 2000-05-11
NZ504420A (en) 2003-08-29
CN1285742A (zh) 2001-02-28
HUP0100098A3 (en) 2001-12-28
HUP0100098A2 (hu) 2001-07-30
NO20002450L (no) 2000-07-14
EE04235B1 (et) 2004-02-16
KR20010032099A (ko) 2001-04-16
AU1160999A (en) 1999-06-07
EA003255B1 (ru) 2003-02-27
TR200001262T2 (tr) 2001-01-22
SK286040B6 (sk) 2008-01-07

Similar Documents

Publication Publication Date Title
FI972584A0 (fi) Substituoituja atsetidin-2-oneja ateroskleroosin hoitamiseksi
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20004688D0 (no) Terapi ved østrogenassosierte lidelser
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
NO20024060D0 (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
HRP980097A2 (en) Combinatory compositions for the treatment of dementia
DZ2649A1 (fr) Association des principes actifs pour le traitement de la démence sénile du type alzheimer.
IS1919B (is) Bensamíð til að meðhöndla taugahrörnunarsjúkdóma
FI971199A0 (fi) Kopolyestereitä
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO944577D0 (no) Hemming av effekten av amyloidogene proteiner
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
KR950030644U (ko) 납골함 안치구조
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
NO20011268D0 (no) Forbindelse til behandling av depresjon
NO930436D0 (no) Fremgangsmaate ved fremstilling av baderom
UA829S (uk) Корпус розгалужувача
FR2771007B1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer
FI944868A0 (fi) Foerfarande foer foerbaettring av en braennare